These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18504578)

  • 1. Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
    Camci C; Sevinc A; Aslan Y; Kalender ME; Buyukberber S
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):745-8. PubMed ID: 18504578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.
    Gorumlu G; Kucukzeybek Y; Kemal-Gul M; Karaca B; Cosan-Terek M; Karabulut B; Sanli UA; Akman L; Ozsaran A; Dikmen Y; Uslu R
    J BUON; 2008; 13(3):349-52. PubMed ID: 18979548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.
    Rose PG; Smrekar M; Haba P; Fusco N; Rodriguez M
    Am J Clin Oncol; 2008 Oct; 31(5):476-80. PubMed ID: 18838885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
    Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
    Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
    Akiyama J; Sagara Y; Takeda Y
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):521-6. PubMed ID: 6422860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    Samaritani R; Corrado G; Vizza E; Sbiroli C
    BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.
    Harter P; Hilpert F; Mahner S; Heitz F; Pfisterer J; du Bois A
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):81-8. PubMed ID: 20014888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy].
    Chen JT; Nakayama K; Shimizu Y; Yokosuka K; Teshima H; Hirai Y; Hamada T; Fujimoto I; Yamauchi K; Hasumi K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):407-12. PubMed ID: 2106837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
    Wada Y; Suzuki M; Shinagawa S; Saito Y; Nishiya I; Maki M; Yajima A; Hiroi M; Sato A
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2589-94. PubMed ID: 2505683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical metastasis as the first manifestation of ovarian papillary serous carcinoma.
    Maki C; Groen J; Delgado B; Piura B
    J Obstet Gynaecol; 2010 Apr; 30(3):325-6. PubMed ID: 20373951
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer].
    Katase K; Shimizu Y; Kobayashi Y; Hasumi K
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):943-7. PubMed ID: 15222118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion].
    Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
    Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
    Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
    Sugawara T; Sakuramoto T; Fukushima S
    Hinyokika Kiyo; 1987 Aug; 33(8):1232-5. PubMed ID: 3122543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of prognostic factors for stage III ovarian epithelial carcinoma].
    Wu M; Shen K; Lang JH; Huang RL; Huang HF; Pan LY
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1406-9. PubMed ID: 16029654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer chemotherapy.
    Christian J; Thomas H
    Cancer Treat Rev; 2001 Apr; 27(2):99-109. PubMed ID: 11319848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.